And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

ADAP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.44%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $80,940.12

Adaptimmune Therapeutics Insider Trading History Chart

Adaptimmune Therapeutics Share Price & Price History

^$1.06

▼ -0.02 (-1.85%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

Adaptimmune Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2024	Adrian Rawcliffe	CEO	Sell	9,304	$0.79	$7,350.16	14,104
1/16/2024	Elliot Norry	Insider	Sell	2,287	$0.79	$1,806.73	3,363
1/16/2024	Willaim C. Bertrand, Jr.	COO	Sell	4,681	$0.79	$3,697.99	7,023
1/12/2024	Willaim C. Bertrand, Jr.	COO	Sell	5,220	$0.85	$4,437.00	7,874
1/11/2024	Adrian Rawcliffe	CEO	Sell	11,945	$0.84	$10,033.80	18,395
1/11/2024	Elliot Norry	Insider	Sell	4,009	$0.84	$3,367.56	6,104
9/1/2023	Adrian Rawcliffe	CEO	Sell	2,403	$0.78	$1,874.34	3,449
8/1/2023	John Lunger	Insider	Sell	3,096	$0.91	$2,817.36	4,718
7/10/2023	Garry E Menzel	Director	Sell	47,702	$0.91	$43,408.82	75,056
6/27/2023	Adrian Rawcliffe	CEO	Sell	2,333	$0.92	$2,146.36	3,519
1/31/2023	Cintia Piccina	Insider	Sell	11,890	$1.87	$22,234.30	19,535
1/17/2023	Adrian Rawcliffe	CEO	Sell	10,057	$1.86	$18,706.02	13,351
1/17/2023	John Lunger	Insider	Sell	4,440	$1.86	$8,258.40	7,264
1/12/2023	Adrian Rawcliffe	CEO	Sell	18,763	$1.71	$32,084.73	24,882
1/12/2023	Willaim C. Bertrand, Jr.	COO	Sell	4,973	$1.71	$8,503.83	8,121
1/11/2023	John Lunger	Insider	Sell	3,843	$1.75	$6,725.25	6,270
1/4/2023	Adrian Rawcliffe	CEO	Sell	5,073	$1.69	$8,573.37	6,631
1/4/2023	John Lunger	Insider	Sell	1,100	$1.69	$1,859.00	1,725
1/4/2023	Willaim C. Bertrand, Jr.	COO	Sell	3,584	$1.69	$6,056.96	5,781
9/1/2022	Adrian Rawcliffe	CEO	Sell	2,536	$1.97	$4,995.92	3,316
8/1/2022	John Lunger	Insider	Sell	2,983	$1.77	$5,279.91	4,829
7/5/2022	John Lunger	Insider	Sell	1,973	$1.68	$3,314.64	3,104
6/27/2022	Adrian Rawcliffe	CEO	Sell	2,562	$1.63	$4,176.06	3,290
5/20/2022	Gavin Wood	CFO	Buy	39,000	$0.29	$11,310.00	96,000
1/18/2022	Adrian Rawcliffe	CEO	Sell	11,096	$3.19	$35,396.24
1/18/2022	Elliot Norry	Insider	Sell	2,121	$3.19	$6,765.99
1/18/2022	Willaim C. Bertrand, Jr.	COO	Sell	4,368	$3.19	$13,933.92
1/12/2022	John Lunger	Insider	Sell	1,076	$3.54	$3,809.04
1/11/2022	Adrian Rawcliffe	CEO	Sell	14,362	$3.56	$51,128.72
1/11/2022	Willaim C. Bertrand, Jr.	COO	Sell	3,770	$3.56	$13,421.20
1/4/2022	Adrian Rawcliffe	CEO	Sell	5,532	$4.06	$22,459.92
1/4/2022	John Lunger	Insider	Sell	1,070	$4.06	$4,344.20
1/4/2022	Willaim C. Bertrand, Jr.	COO	Sell	3,490	$4.06	$14,169.40
9/1/2021	Adrian Rawcliffe	CEO	Sell	2,782	$5.20	$14,466.40
8/2/2021	John Lunger	Insider	Sell	2,939	$3.58	$10,521.62
6/28/2021	Adrian Rawcliffe	CEO	Sell	2,794	$4.37	$12,209.78

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

SEC Filings (Institutional Ownership Changes) for Adaptimmune Therapeutics (NASDAQ:ADAP)

31.37% of Adaptimmune Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adaptimmune Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	JTC Employer Solutions Trustee Ltd	26,156	$41K	0.0%	N/A	0.003%
4/15/2024	Key Client Fiduciary Advisors LLC	268,655	$0.42M	0.2%	-20.2%	0.027%
4/15/2024	Columbia Advisory Partners LLC	15,585	$25K	0.0%	N/A	0.002%
3/5/2024	Twin Focus Capital Partners LLC	55,526	$44K	0.0%	N/A	0.006%
1/26/2024	Baillie Gifford & Co.	15,912,140	$12.62M	0.0%	-7.2%	1.600%
1/9/2024	Key Client Fiduciary Advisors LLC	336,620	$0.27M	0.2%	+6.4%	0.034%
1/8/2024	Harbor Capital Advisors Inc.	147,732	$0.12M	0.0%	+9.9%	0.015%
11/13/2023	Baillie Gifford & Co.	17,147,409	$13.38M	0.0%	-0.2%	1.725%
10/27/2023	Marquette Asset Management LLC	99,349	$77K	0.0%	N/A	0.010%
10/27/2023	Acuitas Investments LLC	479,764	$0.37M	0.2%	N/A	0.048%
10/20/2023	Harbor Capital Advisors Inc.	134,415	$0.11M	0.0%	+19.5%	0.014%
9/21/2023	Barclays PLC	50,061	$46K	0.0%	N/A	0.005%
9/7/2023	MPM Asset Management LLC	6,287,101	$5.82M	2.9%	N/A	0.632%
8/15/2023	Black Maple Capital Management LP	69,839	$65K	0.0%	N/A	0.007%
8/14/2023	X Square Capital LLC	26,771	$25K	0.0%	N/A	0.003%
8/14/2023	CSS LLC IL	90,702	$84K	0.0%	N/A	0.009%
8/11/2023	Artal Group S.A.	1,133,775	$1.05M	0.0%	N/A	0.114%
8/7/2023	Acadian Asset Management LLC	358,010	$0.33M	0.0%	+15.1%	0.036%
8/3/2023	Oppenheimer & Co. Inc.	68,171	$63K	0.0%	N/A	0.007%
7/28/2023	Baillie Gifford & Co.	17,176,135	$15.89M	0.0%	+0.4%	1.728%
7/11/2023	Harbor Capital Advisors Inc.	112,516	$0.10M	0.0%	N/A	0.073%
5/17/2023	Long Focus Capital Management LLC	5,435,439	$5.93M	0.3%	+2.9%	3.514%
5/12/2023	Long Focus Capital Management LLC	2,772,791	$3.02M	0.3%	-47.5%	1.793%
5/10/2023	Simplify Asset Management Inc.	150,000	$0.16M	0.0%	N/A	0.097%
5/3/2023	Baillie Gifford & Co.	17,112,002	$18.65M	0.0%	-0.3%	11.064%
5/1/2023	Virtu Financial LLC	88,234	$96K	0.0%	+193.1%	0.057%
4/25/2023	Key Client Fiduciary Advisors LLC	321,155	$0.35M	0.2%	+8.2%	0.208%
2/15/2023	Endurant Capital Management LP	1,733,236	$2.53M	1.0%	-3.1%	1.058%
2/14/2023	Susquehanna International Group LLP	28,126	$41K	0.0%	N/A	0.017%
2/9/2023	HBK Sorce Advisory LLC	70,000	$65K	0.0%	+100.0%	0.043%
1/17/2023	Key Client Fiduciary Advisors LLC	296,740	$0.43M	0.3%	-31.9%	0.181%
1/11/2023	Vigilare Wealth Management	28,800	$42K	0.0%	-21.7%	0.018%
11/15/2022	PFM Health Sciences LP	9,320,584	$10.02M	0.4%	+2.3%	5.689%
11/15/2022	Long Focus Capital Management LLC	4,789,490	$5.15M	0.5%	+2.4%	2.923%
11/15/2022	Endurant Capital Management LP	1,788,517	$1.92M	0.6%	-1.9%	1.092%
11/14/2022	HBK Sorce Advisory LLC	35,000	$32K	0.0%	N/A	0.021%
11/10/2022	ExodusPoint Capital Management LP	370,288	$0.40M	0.0%	+23.4%	0.227%
11/7/2022	Virtu Financial LLC	40,503	$44K	0.0%	+133.7%	0.025%
11/3/2022	Barclays PLC	340,068	$0.37M	0.0%	+34.6%	0.208%
10/27/2022	Baillie Gifford & Co.	14,664,936	$15.76M	0.0%	-4.3%	8.977%
10/12/2022	Key Client Fiduciary Advisors LLC	435,985	$0.47M	0.4%	+4.8%	0.267%
8/12/2022	Rafferty Asset Management LLC	217,123	$0.37M	0.0%	-59.5%	0.134%
8/11/2022	Alps Advisors Inc.	96,110	$0.16M	0.0%	N/A	0.059%
8/10/2022	Hunter Associates Investment Management LLC	28,500	$49K	0.0%	+42.5%	0.018%
8/8/2022	Baillie Gifford & Co.	15,321,346	$26.05M	0.0%	-0.4%	9.457%
7/11/2022	Vigilare Wealth Management	41,800	$71K	0.1%	N/A	0.026%
5/17/2022	Endurant Capital Management LP	2,160,890	$4.45M	1.2%	+140.7%	1.335%
5/16/2022	Eversept Partners LP	237,086	$0.49M	0.0%	-32.0%	0.151%
5/11/2022	GSA Capital Partners LLP	69,612	$0.14M	0.0%	-17.3%	0.044%
5/5/2022	Baillie Gifford & Co.	15,380,538	$31.68M	0.0%	+11.8%	9.805%
5/5/2022	Levy Wealth Management Group LLC	17,590	$36K	0.0%	N/A	0.011%
4/29/2022	Daiwa Securities Group Inc.	35,516	$73K	0.0%	+44.9%	0.023%
4/26/2022	Hunter Associates Investment Management LLC	20,000	$41K	0.0%	+81.8%	0.013%
4/21/2022	Inspire Investing LLC	31,928	$66K	0.0%	+107.4%	0.020%
4/21/2022	Inspire Advisors LLC	45,105	$93K	0.0%	+193.0%	0.029%
4/18/2022	Key Client Fiduciary Advisors LLC	420,447	$0.87M	0.7%	+58.0%	0.268%
2/14/2022	Long Focus Capital Management LLC	2,162,313	$8.11M	1.1%	N/A	1.384%
2/14/2022	Point72 Asset Management L.P.	565,208	$2.12M	0.0%	+640.8%	0.362%
2/14/2022	DAFNA Capital Management LLC	136,266	$0.51M	0.1%	N/A	0.087%
2/14/2022	Eversept Partners LP	348,716	$1.31M	0.1%	-21.6%	0.223%
2/14/2022	GSA Capital Partners LLP	84,129	$0.32M	0.0%	-82.6%	0.054%
2/11/2022	Syncona Portfolio Ltd	1,377,294	$5.17M	4.9%	N/A	0.882%
2/10/2022	Rafferty Asset Management LLC	606,763	$2.28M	0.0%	-18.1%	0.388%
2/8/2022	Bank of America Corp DE	538,111	$2.02M	0.0%	-26.5%	0.344%
2/8/2022	ProShare Advisors LLC	19,315	$72K	0.0%	-34.0%	0.012%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	69,140	$0.28M	0.0%	+13.6%	0.044%
2/3/2022	Daiwa Securities Group Inc.	24,515	$92K	0.0%	+59.4%	0.016%
2/3/2022	Inspire Investing LLC	15,393	$58K	0.0%	N/A	0.010%
1/27/2022	Hunter Associates Investment Management LLC	11,000	$41K	0.0%	N/A	0.007%
1/20/2022	Baillie Gifford & Co.	13,756,352	$51.59M	0.0%	+7.3%	8.807%
12/1/2021	Balyasny Asset Management LLC	259,413	$1.34M	0.0%	N/A	0.166%
11/18/2021	Personal CFO Solutions LLC	36,388	$0.19M	0.0%	+19.7%	0.023%
11/16/2021	Schonfeld Strategic Advisors LLC	349,683	$1.81M	0.0%	-1.7%	0.224%
11/16/2021	ACT Capital L.L.C.	90,000	$0.47M	0.2%	N/A	0.058%
11/16/2021	Squarepoint Ops LLC	31,881	$0.17M	0.0%	+127.8%	0.020%
11/16/2021	Toroso Investments LLC	10,554	$55K	0.0%	N/A	0.007%
11/16/2021	Millennium Management LLC	1,584,849	$8.19M	0.0%	+70.3%	1.015%
11/15/2021	Point72 Asset Management L.P.	76,300	$0.39M	0.0%	-96.3%	0.049%
11/15/2021	Cubist Systematic Strategies LLC	57,953	$0.30M	0.0%	+485.4%	0.037%
11/15/2021	Man Group plc	148,305	$0.77M	0.0%	+44.2%	0.095%
11/15/2021	Tudor Investment Corp Et Al	16,004	$83K	0.0%	N/A	0.010%
11/15/2021	Rock Springs Capital Management LP	2,189,788	$11.32M	0.2%	+41.7%	1.403%
11/15/2021	Marshall Wace LLP	1,553,800	$8.03M	0.0%	N/A	0.995%
11/15/2021	Balyasny Asset Management LLC	259,413	$1.34M	0.0%	N/A	0.166%
11/15/2021	Wealthspire Advisors LLC	11,750	$61K	0.0%	N/A	0.008%
11/15/2021	Virtus ETF Advisers LLC	47,350	$0.25M	0.1%	-5.0%	0.030%
11/15/2021	Eversept Partners LP	444,887	$2.30M	0.2%	N/A	0.285%
11/15/2021	GSA Capital Partners LLP	484,782	$2.51M	0.3%	-5.6%	0.311%
11/12/2021	Trexquant Investment LP	23,609	$0.12M	0.0%	N/A	0.015%
11/12/2021	Blueshift Asset Management LLC	11,933	$62K	0.0%	N/A	0.008%
11/10/2021	US Bancorp DE	5,729	$29K	0.0%	+403.0%	0.004%
11/10/2021	Goldman Sachs Group Inc.	330,378	$1.71M	0.0%	-13.3%	0.212%
11/10/2021	KBC Group NV	45,900	$0.24M	0.0%	+77.2%	0.029%
11/10/2021	Citigroup Inc.	41,991	$0.22M	0.0%	-15.9%	0.027%
11/10/2021	Rafferty Asset Management LLC	740,915	$3.83M	0.0%	-9.5%	0.475%
11/10/2021	Healthcare of Ontario Pension Plan Trust Fund	60,300	$0.31M	0.0%	-94.1%	0.039%
11/9/2021	BlackRock Inc.	1,260,872	$6.52M	0.0%	+28.5%	0.808%
11/5/2021	Lindbrook Capital LLC	8,667	$45K	0.0%	+31.1%	0.006%
11/5/2021	Daiwa Securities Group Inc.	15,382	$80K	0.0%	+5,908.6%	0.010%
11/1/2021	SG Americas Securities LLC	85,163	$0.44M	0.0%	-63.9%	0.055%

Data available starting January 2016

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; research, collaboration, and license agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Today's Range

Now: $1.06

$1.04

$1.10

50 Day Range

MA: $1.39

$0.90

$1.75

52 Week Range

Now: $1.06

$0.42

$2.05

Volume

565,527 shs

Average Volume

1,754,812 shs

Market Capitalization

$1.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.39

Who are the company insiders with the largest holdings of Adaptimmune Therapeutics?: Adaptimmune Therapeutics' top insider shareholders include:
Gavin Wood (CFO)
Garry E Menzel (Director)
Adrian Rawcliffe (CEO)
Cintia Piccina (Insider)
William C Bertrand Jr (COO)
John Lunger (Insider)
Elliot Norry (Insider)
Learn More about top insider investors at Adaptimmune Therapeutics.
Who are the major institutional investors of Adaptimmune Therapeutics?: Adaptimmune Therapeutics' top institutional shareholders include:
Key Client Fiduciary Advisors LLC — 0.03%
JTC Employer Solutions Trustee Ltd — 0.00%
Columbia Advisory Partners LLC — 0.00%
Learn More about top institutional investors of Adaptimmune Therapeutics stock.
Which institutional investors are selling Adaptimmune Therapeutics stock?: In the last quarter, ADAP stock was sold by these institutional investors:
Key Client Fiduciary Advisors LLC
During the last year, company insiders that have sold Adaptimmune Therapeutics company stock include:
Gavin Wood (CFO)
Garry E Menzel (Director)
Adrian Rawcliffe (CEO)
Cintia Piccina (Insider)
William C Bertrand Jr (COO)
Learn More investors selling Adaptimmune Therapeutics stock.
Which institutional investors are buying Adaptimmune Therapeutics stock?: During the last quarter, ADAP stock was acquired by institutional investors including:
JTC Employer Solutions Trustee Ltd
Columbia Advisory Partners LLC